Tobramycin Levels Obtained from Central Venous Access Devices

November 2008
Pediatric Nursing;Nov/Dec2008, Vol. 34 Issue 6, p468
Academic Journal
A quiz related to the accuracy of tobramycin levels obtained from central venous access devices (CVADs) is presented.


Related Articles

  • Comparative Cost Effectiveness of Gentamicin and Tobramycin. Holloway, James J.; Smith, Craig R.; Moore, Richard D.; Feroli Jr., E. Robert; Lietman, Paul S. // Annals of Internal Medicine;Dec84, Vol. 101 Issue 6, p764 

    Compares antibacterial agents gentamicin and tobramycin for cost effectiveness in the treatment of adult patients with serious infections in a general medical service. Frequency of nephrotoxicity in gentamicin and tobramycin; Estimated incremental costs attributable to nephrotoxicity;...

  • International abstracts. Smith, Jeanette M. // JAMA: Journal of the American Medical Association;10/26/94, Vol. 272 Issue 16, p1234g 

    Presents an abstract of the study `Synergy Between Tobramycin and Netilmicin Against Three Strains of Methicillin and Gentamicin Resistant Staphylococci (S. epidermis, S. aureus),' by Donadieu Ratovohery et al. Antibacterial effect of tobramycin-netilmicin combination on multiresistant strains...

  • Tobradex.  // Royal Society of Medicine: Medicines;2002, p538 

    This article provides information on Tobradex, a proprietary, prescription-only compound preparation of the anti-inflammatory and corticosteroid dexamethasone and the antibacterial and antibiotic tobramycin. It can be used to treat inflammation of the eye when infection is also present. The drug...

  • Randomized controlled monocentric comparison of once daily ceftriaxone with tobramycin and cefotaxime three times daily with tobramycin in neutropenic fever. Cornely, O. A.; Bethe, U.; Salzberger, B.; Franzen, C.; Hartmann, P.; Steinmetz, T.; Fätkenheuer, G.; Seifert, H.; Diehl, V.; Schrappe, M. // Annals of Hematology;Feb2001, Vol. 80 Issue 2, p103 

    A prospective, randomized, controlled monocentric trial was performed to evaluate the efficacy and safety of once daily ceftriaxone 2 g plus tobramycin 5 mg/kg in comparison to cefotaxime 2 g t.i.d. plus tobramycin 5 mg/kg qd in the treatment of neutropenic fever. In cases of fever ≥38.5...

  • Antibiotic/steroid combination controls BKC inflammation. Groves, Nancy; Kornmehl, Ernest W.; Mah, Francis S. // Ophthalmology Times;6/1/2007, Vol. 32 Issue 11, p34 

    The article presents a study which compares the effectiveness of tobramycin 0.3%/dexamethasone 0.1% and trobramycin 0.3%/loteprednol 0.5% in controlling inflammation in patients with blepharokeratoconjunctivitis (BKC). The study utilizes 40 patients who were randomly assigned to receive one of...

  • Combination agents equivalent in reducing blepharokeratoconjunctivitis signs, symptoms. Groves, Nancy // Ophthalmology Times;3/15/2008, Vol. 33 Issue 9, p32 

    The article focuses on a study regarding the use of two combination agents in reducing the symptoms of blepharokeratoconjunctivitis. The study conducted by Jonathan Macy and colleagues reported the efficacy of loteprednol-tobramycin and dexamethasone-tobramycin in reducing ocular inflammation...

  • Gentamicin and Tobramycin Binding to Human Serum In Vitro. Bailey, David N.; Briggs, John R. // Journal of Analytical Toxicology;Apr2004, Vol. 28 Issue 3, p187 

    Studies the binding of gentamicin and tobramycin to human serum in vitro using equilibrium dialysis of pooled human serum supplemented to various concentrations of either drug. Minimal and variable non-specific binding found for each drug; Failure to identify any specific binding proteins.

  • Tobi.  // Royal Society of Medicine: Medicines;2002, p538 

    This article provides information on Tobi, a proprietary, prescription-only preparation of the antibacterial and antibiotic tobramycin. The drug can be used to treat serious bacterial infections, particularly Pseudomonas aeruginosa infection in cystic fibrosis patients over six years. It is is...

  • tobramycin.  // Royal Society of Medicine: Medicines;2002, p538 

    This article provides information on tobramycin, an antibacterial and antibiotic drug of the aminoglycoside group. The drug is effective against some Gram-positive and Gram-negative bacteria and is used primarily for the treatment of serious Gram-negative infections caused by Pseudomonas...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics